UY SQNM @ 3.19.

2009-Sep-29 06:27:29: BUY  SQNM @ 3.19.  Shares of Sequenom Inc. plunged in early action Tuesday, a day after the biotech company announced that an independent group of investigators has confirmed that data supporting the accuracy of its new prenatal test for Down syndrome are invalid. “We are no longer relying on, and the public should no longer rely on, any of our previously announced test data and results for our noninvasive prenatal test for [Down Syndrome]  Sequenom had been hoping to originally launch the test, which has been considered key to its long-term financial success, in 2009. SPM+Game Theory 68 LONG with EXIT POINT $6.25.